10 Most Promising Cancer Drugs Not Yet Approved in 2025: Solid Tumors Edition by OncoDaily
Bernard A. Fox: Myriam Chalabi Takes Cancer Immunotherapy Beyond MSI High
FDA to Shift Toward Single-Study Requirement for Drug and Medical Product Approvals
ASCO Leadership Development Program is Now Coming to Central and Eastern Europe
Key Results from the ESO-Shanghai 17 and 9 Trials: Small T-Field Postoperative ChemoRT Shows Safer Profile in Resected ESCC
U.S. House of Representatives Passed the Mikaela Naylon Give Kids A Chance Act - ACS CAN
Grand Opening of START New York-Long Island Clinical Trial Unit
Shane Jacobson: New Cervical Cancer Screening Guideline Update from the ACS
